These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5394959)

  • 21. Differences in efficiency, satisfaction and adverse events between self-administered intradermal and nurse-administered intramuscular influenza vaccines in hospital workers.
    Coleman BL; McNeil SA; Langley JM; Halperin SA; McGeer AJ
    Vaccine; 2015 Nov; 33(48):6635-40. PubMed ID: 26529074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of an adsorbed trivalent split influenza vaccine administered by intradermal route.
    Niculescu IT; Zilişteanu E; Alexandrescu V; Maţepiuc M; Creţescu L; Ionescu N; Molnar G; Răcăşan R; Mogoş A
    Arch Roum Pathol Exp Microbiol; 1981; 40(1):67-70. PubMed ID: 7185350
    [No Abstract]   [Full Text] [Related]  

  • 23. Larger dose of intradermal influenza vaccination may be more immunogenic in transplant recipients.
    Mossad SB
    Am J Transplant; 2008 May; 8(5):1073; author reply 1074. PubMed ID: 18318782
    [No Abstract]   [Full Text] [Related]  

  • 24. [Novel approaches for the prevention of influenza: the intradermal vaccination].
    Durando P; Sticchi L; Alberti M; Alicino C; Iudici R; Martini M; Icardi G
    Ig Sanita Pubbl; 2010; 66(3):387-400. PubMed ID: 20859311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intradermal influenza vaccination--can less be more?
    La Montagne JR; Fauci AS
    N Engl J Med; 2004 Nov; 351(22):2330-2. PubMed ID: 15525715
    [No Abstract]   [Full Text] [Related]  

  • 26. The intradermal vaccination: past experiences and current perspectives.
    Sticchi L; Alberti M; Alicino C; Crovari P
    J Prev Med Hyg; 2010 Mar; 51(1):7-14. PubMed ID: 20853670
    [No Abstract]   [Full Text] [Related]  

  • 27. Dose sparing with intradermal injection of influenza vaccine.
    Kenney RT; Frech SA; Muenz LR; Villar CP; Glenn GM
    N Engl J Med; 2004 Nov; 351(22):2295-301. PubMed ID: 15525714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination.
    Morelon E; Pouteil Noble C; Daoud S; Cahen R; Goujon-Henry C; Weber F; Laurent PE; Kaiserlian D; Nicolas JF
    Vaccine; 2010 Oct; 28(42):6885-90. PubMed ID: 20709000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.
    Arnou R; Icardi G; De Decker M; Ambrozaitis A; Kazek MP; Weber F; Van Damme P
    Vaccine; 2009 Dec; 27(52):7304-12. PubMed ID: 19849996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative and qualitative analysis of antibody response after dose sparing intradermal 2009 H1N1 vaccination.
    Hung IF; Levin Y; To KK
    Vaccine; 2012 Apr; 30(17):2707-8. PubMed ID: 22210225
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunogenicity and safety of intradermal trivalent influenza vaccination in nursing home older adults: a randomized controlled trial.
    Chan TC; Hung IF; Chan KH; Li CP; Li PT; Luk JK; Chu LW; Chan FH
    J Am Med Dir Assoc; 2014 Aug; 15(8):607.e5-12. PubMed ID: 24957950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceptance of Intanza® 9 μg intradermal influenza vaccine in routine clinical practice in Australia and Argentina.
    Eizenberg P; Booy R; Naser N; Mason G; Stamboulian D; Weber F
    Adv Ther; 2011 Aug; 28(8):640-9. PubMed ID: 21751080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.
    Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M
    J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain.
    Hung IF; Levin Y; To KK; Chan KH; Zhang AJ; Li P; Li C; Xu T; Wong TY; Yuen KY
    Vaccine; 2012 Oct; 30(45):6427-35. PubMed ID: 22910287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influenza vaccines dispensed in community pharmacies during the 2010-2011 flu season].
    De Bruyn K; Hamelinck W
    J Pharm Belg; 2011 Dec; (4):117-21. PubMed ID: 22299238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial.
    Chiu SS; Chan KH; Tu W; Lau YL; Peiris JS
    Vaccine; 2009 Jul; 27(35):4834-9. PubMed ID: 19523908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acceptance and opinions of Intanza/IDflu intradermal influenza vaccine in the Czech Republic and Turkey.
    Prymula R; Usluer G; Altinel S; Sichova R; Weber F
    Adv Ther; 2012 Jan; 29(1):41-52. PubMed ID: 22228256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.
    Leroux-Roels I; Vets E; Freese R; Seiberling M; Weber F; Salamand C; Leroux-Roels G
    Vaccine; 2008 Dec; 26(51):6614-9. PubMed ID: 18930093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intradermal injections of influenza vaccine.
    Mortimer EA
    Pediatrics; 1968 Nov; 42(5):875. PubMed ID: 5685373
    [No Abstract]   [Full Text] [Related]  

  • 40. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer.
    Jo YM; Song JY; Hwang IS; Lee J; Oh SC; Kim JS; Kim SR; Kim WJ; Cheong HJ
    J Med Virol; 2009 Apr; 81(4):722-7. PubMed ID: 19235853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.